NRx Pharmaceuticals (NRXP) Appoints Stephen Willard as CEO and Director
Go back to NRx Pharmaceuticals (NRXP) Appoints Stephen Willard as CEO and Director| (NASDAQ: NRXP) | Delayed: 2.89 -0.01 (0.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.90 | 52 Week High | $ | |||
| Open | $2.88 | 52 Week Low | $ | |||
| Day High | $2.90 | P/E | N/A | |||
| Day Low | $2.81 | EPS | $ | |||
| Volume | 651,706 | |||||



